Skip to content

Levetiracetam showed mixed cognitive results in adults with cognitive decline

Compared with placebo, levetiracetam did not clearly improve a global cognition measure in adults with cognitive decline. Visual and spatial test performance improved, while evidence for executive function remained uncertain.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review did not establish an improvement in global cognition with levetiracetam compared with placebo. It found improvement on tests of visual and spatial function, but the executive-function result remained uncertain. Adverse events did not clearly differ between groups. This mixed pattern does not establish a broad cognitive benefit or demonstrate that the medication slows decline.

Keep in mind

The abstract omits treatment lengths and does not translate score differences into everyday functioning. The authors call for larger studies and more consistent testing, limiting how confidently these domain-specific results can be interpreted.

THE RESULT, WITH CONTEXT

What researchers found

No statistically clear improvement in global cognition

Global cognition measure, reported as CDR-SB

Levetiracetam versus placebo across contributing trials; follow-up length and score units are not specified.

Epilepsia Open, 2025 · Original source ↓

Different tests gave different answers

Global cognition and specific cognitive skills were assessed separately. The favorable visual and spatial result concerns test performance in that domain. It does not establish improvement across all cognitive skills or in daily activities.

Executive function and adverse events

Executive function refers to skills involved in organizing and managing tasks. Its pooled result was compatible with no difference. The absence of a detected adverse-event difference also leaves uncertainty, rather than proving equal safety.

CHECK THE ORIGINAL

The original publication

Effect of levetiracetam on cognition in patients with cognitive decline: A systematic review and meta-analysis of randomized controlled trials.

Faini C, Sen A, Romoli M
Epilepsia Open · 2025

PubMed ID
40608289
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.